CFDA official statement: the six generic drugs can also use the "pass consistency evaluation" logo

Source: Medical magic cube data on May 22, 2018, CFDA released the fourth batch of 12 drug lists that passed the consistency evaluation So far, CFDA has published 41 drugs that have passed the consistency evaluation in four batches In addition to the fourth batch of drugs passing the consistency evaluation, CFDA also re emphasized the use standard of "passing the consistency evaluation" logo while publishing the list, and issued the document "notes on matters related to the use of" passing the consistency evaluation "logo" In particular, the document points out that generic drugs included in the catalogue of interchangeable drugs with the original research drugs, i.e the catalogue of drugs on the market in China, can use the mark of "pass consistency evaluation" Through inquiry, the catalogue of Chinese listed drugs currently contains 105 drugs (according to the regulations), including 67 imported original research drugs, 10 innovative drugs, 22 drugs that pass the consistency evaluation of quality and efficacy (it is speculated that the data update lags behind, only the first two batches published by CFDA), and 6 generic drugs approved according to the new registration and classification of chemical drugs That is to say, in addition to the 41 drugs published in four batches, at least the following 6 generic drugs approved according to the new registration classification of chemical drugs can also use the "pass consistency evaluation" logo, which means that they are consistent with the quality and efficacy of the original research and can enjoy preferential treatment in terms of bidding and procurement policies Sichuan Huiyu's pemetrexed for injection should be familiar with the new 4 categories of generic drugs included in the catalogue of Chinese listed drugs It is the first generic injection drug included in the catalogue of Chinese listed drugs after the new 4 categories of approval Although CFDA has previously stated that "generic drugs approved according to the new registration classification are deemed to pass the conformity assessment", it is the first time to officially state that the new four generic drugs are allowed to use the "pass the conformity assessment" logo In fact, CFDA's statement once again highlights the importance of the catalogue of Chinese listed drugs for guiding patients to use drugs - all drugs included in the catalogue of Chinese listed drugs are drugs with reliable quality! However, from the perspective of query results, it is obvious that the catalogue of Chinese drugs on the market, which is endowed with the color of "China orange book", is still not in place, for example, the information is not updated in time, the data fields are not complete, etc It is also hoped that the relevant departments will attach importance to the construction of the catalogue of Chinese listed drugs.